Durable biochemical response and safety with oral octreotide capsules in acromegaly

Objective The objective of this study is to report results from the open-label extension (OLE) of the OPTIMAL trial of oral octreotide capsules (OOC) in adults with acromegaly, evaluating the long-term durability of therapeutic response. Design The study design is an OLE of a double-blind placebo-co...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of endocrinology 2022-12, Vol.187 (6), p.733-741
Hauptverfasser:	Samson, Susan L, Nachtigall, Lisa B, Fleseriu, Maria, Jensterle, Mojca, Manning, Patrick J, Elenkova, Atanaska, Molitch, Mark E, Ludlam, William H, Patou, Gary, Haviv, Asi, Biermasz, Nienke R, Giustina, Andrea, Strasburger, Christian J, Kennedy, Laurence, Melmed, Shlomo
Format:	Artikel
Sprache:	eng
Schlagworte:	Acromegaly Insulin Insulin-like growth factor I Octreotide Original Original Research Placebos
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!